Becton Dickinson(BDX)

FRANKLIN LAKES, NJMedical Devices2 H-1B visas (FY2023)

Focus: Becton Dickinson is a 50,000+ person public medical device company headquartered in New Jersey, generating $19.4B in FY2025 revenue across infection prevention, vascular access, diabetes management, and diagnostic systems.

Profile data last refreshed 7h ago · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

50000+

Open Jobs

4 recent layoff filings (12 mo) — 238 affected

10/31/2025 — 3750 Torrey View Court San Diego CA 92130, CA · 59 affected · Layoff
10/31/2025 — 10020 Pacific Mesa Boulevard San Diego CA 92121, CA · 7 affected · Layoff
10/1/2025 — Franklin Lakes, NJ · 86 affected · Layoff
+1 more

Source: state DOL filings via Big Local News

About Becton Dickinson

AI assessmentNot Hiring

No open roles listed right now. Follow Becton Dickinson to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

6/9 — Partial

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

4 imminent

CHLORAPREP ONE-STEP

Hiring

Stable

Revenue

$19.4B

FY2025

Key Products

CHLORHEXIDINE GLUCONATE

Surgical Site Infection, Healthcare Associated Infection, Nosocomial Infection

$623M Part D

Pre-Launch

Antimicrobial oral rinse in pre-launch phase; represents core revenue concentration reported by company, but lifecycle status suggests either new formulation or market entry lag.

Help build intelligence for Becton Dickinson

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

BD MiniDraw Capillary System

Healthy

N/A

BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes

Anesthesia

N/A

Clinical Trials (1)

NCT05953363Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.

N/A

IUO CLPD Limited Panel

Chronic Lymphoproliferative Diseases (CLPD)

N/A

Clinical Trials (1)

NCT05032313Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer

N/A

BD Onclarity™ HPV assay

Cervical Intraepithelial Neoplasia Grade 2/3

N/A

Clinical Trials (1)

NCT04788849Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples

N/A

Immune Failure in Critical Therapy (INFECT) Study

Sepsis

N/A

Clinical Trials (1)

NCT02186522Immune Failure in Critical Therapy (INFECT) Study

N/A

Colposcopy/biopsy

Uterine Cervical Neoplasm

N/A

Clinical Trials (1)

NCT03020121Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

N/A

StatLock™ Catheter Stabilization Device and the StatLock™ stabilization device accessory

Peripheral Intravenous Catheter Stabilization

N/A

Clinical Trials (1)

NCT04845906A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

N/A

BD Onclarity™ HPV assay on BD Viper™ LT

Uterine Cervical Neoplasms

N/A

Clinical Trials (1)

NCT01944722Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

N/A

BD PosiFlush™ SafeScrub

CRBSI - Catheter Related Bloodstream Infection

N/A

Clinical Trials (1)

NCT06604026Investigational Study With the BD PosiFlush™ SafeScrub on NADs

N/A

Peripheral Intravenous Catheter

Indication for Peripheral Intravenous Catheterisation

N/A

Clinical Trials (1)

NCT04344314Impact of PIVC Length and Gauge on Catheter Indwell Time

N/A

Randomized Traditional

Catheter Related Complication

N/A

Clinical Trials (1)

NCT04811430Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study

N/A

IUO Plasma Cell Disorders Panel

Plasma Cell Disorder

N/A

Clinical Trials (1)

NCT05032339Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

N/A

BD PureHub™ Disinfecting Cap Placements: Attachments/removals

Catheter Related Complication

N/A

Clinical Trials (1)

NCT05130762A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

N/A

molecular assays to screen for eXDR

Multidrug-resistant Bacteria Screening

N/A

Clinical Trials (1)

NCT05200546Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management

N/A

test Aerobic/F Culture Vials

Sepsis

N/A

Clinical Trials (1)

NCT06426121Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product

N/A

Capillary Blood Collection System

Healthy

N/A

Clinical Trials (1)

NCT05186311BD MiniDraw™ Capillary System Clinical Equivalence Study

N/A

PureWick™ System

Urinary Incontinence

N/A

Clinical Trials (1)

NCT06850259This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.

N/A

BD Prevue

BD Prevue II for Peripheral Intravenous Catheter Placement

N/A

Clinical Trials (1)

NCT06632496BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study

N/A

Detection and isolation of C. difficile carriers

Clostridium Difficile

N/A

Clinical Trials (1)

NCT03223415Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections

N/A

PureWick™ System

Nocturnal Enuresis

N/A

Clinical Trials (1)

NCT05710718PureWick™ France and U.S. At-Home Pilot Study

N/A

European Sepsis Care Survey

Sepsis

N/A

Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study

Sepsis

N/A

Clinical Trials (1)

NCT02188992Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study

N/A

Securis™ Stabilization Device

Peripheral Intavenous Catheter Stabilization

N/A

Clinical Trials (1)

NCT04841330Prospective Healthy Volunteer Study of the Securis™ Stabilization Device

N/A

BD SiteRite

BD SiteRite 9 for VAD Insertion

N/A

Clinical Trials (1)

NCT06632509BD SiteRite(TM) 9 Ultrasound System - Clinical Study

N/A

Securis Stabilization Device

Peripheral Intavenous Catheter Stabilization

N/A

BD FACSLyric Flow Cytometer

Plasma Cell Disorder

N/A

On-body Injector

Healthy Volunteers

N/A

Clinical Trials (1)

NCT05553418Investigational On-body Injector Clinical Study

N/A

CHG/IPA

Microbial Colonization

N/A

Clinical Trials (1)

NCT04035161Evaluation of the Antimicrobial Effectiveness of CHG/IPA

N/A

BD Scarlett Infusion Set

Diabetes

N/A

BD Spinal Needle

Anesthesia

N/A

Clinical Trials (1)

NCT05214560Prospective Clinical Evaluation of BD Spinal Needles

N/A

PowerMe Midline Catheter

Catheterization

N/A

Clinical Trials (1)

NCT04719377A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter in the Chinese Population

N/A

BD NRFit Devices

Anesthesia

N/A

BD OneFlow LST, and B-CLPD T1 to T4 Assays

Chronic Lymphoproliferative Diseases (CLPD)

N/A

Clinical Trials (1)

NCT05557422BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

N/A

MiniMed Pro-set

Diabetes Mellitus, Type 1

N/A

BD OneFlow Acute Leukemia Panel

Acute Leukemia

N/A

Clinical Trials (1)

NCT05035615Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

N/A

Optimal insulin injection

Diabetes Mellitus, Type 2

N/A

BD Nano Pen Needle

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT04090242Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes

N/A

BD Pen Needle 4mm x 32G

Diabetes Mellitus

N/A

BD Fingerstick Lancet

Diabetes Mellitus, Type 1

N/A

HPV Genotyping Nucleic Acid Assay Kit

Cervical Cancer

N/A

Clinical Trials (1)

NCT04461678Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit

N/A

BD NEXT Pen Needle

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT01852136Clinical Evaluation of BD NEXT Pen Needle

N/A

BD FlowSmart Subcutaneous Insulin Infusion Set

Type 1 Diabetes Mellitus

N/A

BD 2nd Generation Continuous Glucose Sensor

Diabetes

N/A

Clinical Trials (1)

NCT01645696Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics

N/A

Social determinants of health screening

Lung Cancer

N/A

Clinical Trials (1)

NCT06052449Assessing Social Determinants of Health to Increase Cancer Screening

N/A

Ingestion of BD glucose tablets

Type 1 Diabetes Mellitus

N/A

Clinical Trials (1)

NCT00706693Skittles(TM) Effective for Treating Hypoglycemia in Children With Type 1 Diabetes

N/A

Chest Drain Insertion and Talc Pleurodesis

Pleural Effusion, Malignant

N/A

Clinical Trials (1)

NCT02517749Out Patient Talc Slurry Via Indwelling Pleural Catheter for Malignant Pleural Effusion Vs Usual Inpatient Management

N/A

Terumo Nanopass® 34G pen needle

Diabetes

N/A

Clinical Trials (1)

NCT03878745Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle

N/A

BD/33G

Diabetes Mellitus, Type 1

N/A

Clinical Trials (1)

NCT00741390Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose

N/A

4 mm x 32G Pen Needle

Diabetes Mellitus, Type 1

N/A

Clinical Trials (1)

NCT01231984Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

N/A

Online education

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT04659330Lipohypertrophy Monitoring Study

N/A

Interview Prep Quick Facts

Portfolio: 17 approved products, 78 clinical trials

Top TAs: Metabolic Diseases, Oncology, Infectious Diseases

H-1B (2023): 2 approvals

Publications: 27 in PubMed

SEC Filings: 2 available

Portfolio Health

Pre-Launch1 (6%)

Peak1 (6%)

LOE Approaching14 (82%)

Post-LOE1 (6%)

17 total products

Therapeutic Area Focus

23 pipeline

10 pipeline

3 marketed4 pipeline

3 marketed1 pipeline

Financials (FY2025)

Revenue

$19.4B3%

R&D Spend

$1.2B(6%)2%

Net Income

$1.5B

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Risk Signals

WARN Act Layoff Notices (4)

2025-10-31

59 employees affected— 3750 Torrey View Court San Diego CA 92130, CA

source

2025-10-31

7 employees affected— 10020 Pacific Mesa Boulevard San Diego CA 92121, CA

source

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Treating native arteries, bypasses and in-stent-restenosis with rotational athero-thrombectomy - two-year results from the Rotarex-PMCF trial.

VASA. Zeitschrift fur Gefasskrankheiten

2026

PMID:42035487

Design Differences and Usability Risks in GLP-1 Pen Injectors: A Comparative Study of a Generic and Reference Device.

Becton Dickinson(BDX)

About Becton Dickinson

Why Work Here

Key Products

Watch Out For

Products & Portfolio (2)

Pipeline & Clinical Trials

Recent News · Becton Dickinson(10)

Open Jobs (0)

Financials (FY2025)

Hiring Trend

Visa Sponsorship

Risk Signals

WARN Act Layoff Notices (4)

Research Publications(10)